RU2145965C1 - Биологически активные полимерсвязанные антрациклины, промежуточные соединения, способы получения и фармацевтическая композиция - Google Patents

Биологически активные полимерсвязанные антрациклины, промежуточные соединения, способы получения и фармацевтическая композиция Download PDF

Info

Publication number
RU2145965C1
RU2145965C1 RU94046336A RU94046336A RU2145965C1 RU 2145965 C1 RU2145965 C1 RU 2145965C1 RU 94046336 A RU94046336 A RU 94046336A RU 94046336 A RU94046336 A RU 94046336A RU 2145965 C1 RU2145965 C1 RU 2145965C1
Authority
RU
Russia
Prior art keywords
gly
leu
general formula
anthracycline
phe
Prior art date
Application number
RU94046336A
Other languages
English (en)
Russian (ru)
Other versions
RU94046336A (ru
Inventor
Ангелуччи Франческо
Гранди Мария
Сюарато Антонино
Original Assignee
Фармация Энд Апджон С.П.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Фармация Энд Апджон С.П.А. filed Critical Фармация Энд Апджон С.П.А.
Publication of RU94046336A publication Critical patent/RU94046336A/ru
Application granted granted Critical
Publication of RU2145965C1 publication Critical patent/RU2145965C1/ru

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/582—Recycling of unreacted starting or intermediate materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polyamides (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
RU94046336A 1993-05-11 1994-04-08 Биологически активные полимерсвязанные антрациклины, промежуточные соединения, способы получения и фармацевтическая композиция RU2145965C1 (ru)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9309663.4 1993-05-11
GB9309663,4 1993-05-11
GB939309663A GB9309663D0 (en) 1993-05-11 1993-05-11 Biologically active compounds
PCT/EP1994/001100 WO1994026311A1 (en) 1993-05-11 1994-04-08 Anthracycline conjugates, their preparation and their use as antitumor agents

Publications (2)

Publication Number Publication Date
RU94046336A RU94046336A (ru) 1996-10-27
RU2145965C1 true RU2145965C1 (ru) 2000-02-27

Family

ID=10735264

Family Applications (1)

Application Number Title Priority Date Filing Date
RU94046336A RU2145965C1 (ru) 1993-05-11 1994-04-08 Биологически активные полимерсвязанные антрациклины, промежуточные соединения, способы получения и фармацевтическая композиция

Country Status (25)

Country Link
US (1) US5571785A (cg-RX-API-DMAC7.html)
EP (1) EP0649312B1 (cg-RX-API-DMAC7.html)
JP (1) JPH08502519A (cg-RX-API-DMAC7.html)
KR (1) KR100330635B1 (cg-RX-API-DMAC7.html)
CN (1) CN1098106C (cg-RX-API-DMAC7.html)
AT (1) ATE203414T1 (cg-RX-API-DMAC7.html)
AU (1) AU671741B2 (cg-RX-API-DMAC7.html)
CA (1) CA2136438C (cg-RX-API-DMAC7.html)
DE (1) DE69427799T2 (cg-RX-API-DMAC7.html)
DK (1) DK0649312T3 (cg-RX-API-DMAC7.html)
ES (1) ES2161764T3 (cg-RX-API-DMAC7.html)
FI (1) FI112602B (cg-RX-API-DMAC7.html)
GB (1) GB9309663D0 (cg-RX-API-DMAC7.html)
GR (1) GR3036978T3 (cg-RX-API-DMAC7.html)
HU (2) HUT70509A (cg-RX-API-DMAC7.html)
IL (1) IL109528A (cg-RX-API-DMAC7.html)
MY (1) MY110974A (cg-RX-API-DMAC7.html)
NZ (1) NZ265266A (cg-RX-API-DMAC7.html)
PL (1) PL175325B1 (cg-RX-API-DMAC7.html)
PT (1) PT649312E (cg-RX-API-DMAC7.html)
RU (1) RU2145965C1 (cg-RX-API-DMAC7.html)
TW (1) TW268015B (cg-RX-API-DMAC7.html)
UA (1) UA42695C2 (cg-RX-API-DMAC7.html)
WO (1) WO1994026311A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA943212B (cg-RX-API-DMAC7.html)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2341530C2 (ru) * 2003-07-02 2008-12-20 Солакс Корпорейшн Термостойкий кристаллический гидрохлорид эпирубицина и способ его получения

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9320781D0 (en) * 1993-10-08 1993-12-01 Erba Carlo Spa Polymer-bound camptothecin derivatives
GB9721069D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Polymeric derivatives of camptothecin
GB9721070D0 (en) 1997-10-03 1997-12-03 Pharmacia & Upjohn Spa Bioactive derivatives of camptothecin
CA2445985A1 (en) * 2001-05-04 2002-11-14 University Of Utah Research Foundation Hyaluronic acid containing bioconjugates: targeted delivery of anti-cancer drugs to cancer cells
US7049285B2 (en) * 2001-10-31 2006-05-23 Myung-Ok Park Biocompatible polymers including peptide spacer
US20050169883A1 (en) * 2002-05-06 2005-08-04 Prestwich Glenn D. Preblocking with non-ha gags increases effectiveness of ha conjugated anticancer agents
IL325256A (en) 2014-06-13 2026-02-01 Bach Biosciences Llc FAP-activated medical materials and related uses
WO2015192124A1 (en) * 2014-06-13 2015-12-17 Trustees Of Tufts College Fap-activated therapeutic agents, and uses related thereto

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0298385A2 (de) * 1987-07-09 1989-01-11 BEHRINGWERKE Aktiengesellschaft Zytostatisch wirksame Anthracyclin-Derivate
SU1590045A3 (ru) * 1986-06-12 1990-08-30 Фармиталиа Карло Эрба С.П.А.(Фирма) Способ получени гликозида
EP0392487A2 (en) * 1989-04-13 1990-10-17 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines
EP0514515A1 (en) * 1990-12-05 1992-11-25 Erba Carlo Spa ANTHRACYCLINE CONJUGATE.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5162512A (en) * 1982-03-09 1992-11-10 Cytogen Corporation Amine derivatives of anthracycline antibodies
JPS60246400A (ja) * 1984-05-22 1985-12-06 Ajinomoto Co Inc アントラサイクリン系化合物及び制ガン剤
US5169937A (en) * 1986-11-18 1992-12-08 The Scripps Research Institute Method for producing stable glycosylated hemoglobin
GB9017024D0 (en) * 1990-08-03 1990-09-19 Erba Carlo Spa New linker for bioactive agents

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1590045A3 (ru) * 1986-06-12 1990-08-30 Фармиталиа Карло Эрба С.П.А.(Фирма) Способ получени гликозида
EP0298385A2 (de) * 1987-07-09 1989-01-11 BEHRINGWERKE Aktiengesellschaft Zytostatisch wirksame Anthracyclin-Derivate
EP0392487A2 (en) * 1989-04-13 1990-10-17 Takeda Chemical Industries, Ltd. Stabilized composition of anthracyclines
EP0514515A1 (en) * 1990-12-05 1992-11-25 Erba Carlo Spa ANTHRACYCLINE CONJUGATE.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Macromolekulare chemie, Macromolecular Symposia 70/71, 1993, Basel CH, p.157 - 162. R.Duncan et al. "Development of N-(2-hydroxypropyl) methacrylamide copolymer conjugates for delivery of cancer chemotherapy". Аркамон А.Ф. Доксорубицин. - Medical chemistry monograph, т.17, Academic Press, 1981. *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2341530C2 (ru) * 2003-07-02 2008-12-20 Солакс Корпорейшн Термостойкий кристаллический гидрохлорид эпирубицина и способ его получения

Also Published As

Publication number Publication date
HU9403811D0 (en) 1995-03-28
PT649312E (pt) 2002-01-30
FI946128A7 (fi) 1994-12-28
CA2136438A1 (en) 1994-11-24
WO1994026311A1 (en) 1994-11-24
DE69427799T2 (de) 2002-05-02
JPH08502519A (ja) 1996-03-19
NZ265266A (en) 1996-06-25
EP0649312B1 (en) 2001-07-25
GR3036978T3 (en) 2002-01-31
PL306861A1 (en) 1995-04-18
CN1098106C (zh) 2003-01-08
KR950702201A (ko) 1995-06-19
CA2136438C (en) 2004-09-14
ATE203414T1 (de) 2001-08-15
AU671741B2 (en) 1996-09-05
IL109528A (en) 1998-08-16
IL109528A0 (en) 1994-08-26
UA42695C2 (uk) 2001-11-15
KR100330635B1 (ko) 2002-09-17
DE69427799D1 (de) 2001-08-30
AU6566694A (en) 1994-12-12
ZA943212B (en) 1995-01-18
PL175325B1 (pl) 1998-12-31
HU211538A9 (en) 1995-12-28
EP0649312A1 (en) 1995-04-26
DK0649312T3 (da) 2001-11-12
TW268015B (cg-RX-API-DMAC7.html) 1996-01-11
FI946128A0 (fi) 1994-12-28
FI112602B (fi) 2003-12-31
CN1108454A (zh) 1995-09-13
MY110974A (en) 1999-07-31
RU94046336A (ru) 1996-10-27
HUT70509A (en) 1995-10-30
ES2161764T3 (es) 2001-12-16
GB9309663D0 (en) 1993-06-23
US5571785A (en) 1996-11-05

Similar Documents

Publication Publication Date Title
AU679788B2 (en) Polymer-bound camptothecin derivatives
AU659750B2 (en) Polymer-bound paclitaxel derivatives
KR101057102B1 (ko) 캄프토테신의 고분자량 유도체
CA2208841C (en) High molecular weight polymer-based prodrugs
KR100387191B1 (ko) 캄프토테신유도체
JP4039466B2 (ja) 新規アンスラサイクリン系化合物誘導体及びそれを含む医薬製剤
JPWO1997012895A1 (ja) 新規アンスラサイクリン系化合物誘導体及びそれを含む医薬製剤
EP0649312B1 (en) Anthracycline conjugates, their preparation and their use as antitumor agents
JP2001510486A (ja) カンプトテシンの生物活性誘導体
JPS6253934A (ja) 新規のプロドラツグ及びその製法
JPH06321927A (ja) 抗腫瘍ミトキサントロンのポリマー組成物
KR0169195B1 (ko) PVMA-Ara-C 결합체

Legal Events

Date Code Title Description
MM4A The patent is invalid due to non-payment of fees

Effective date: 20060409